Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands.
Saved in:
| Title: | Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands. |
|---|---|
| Authors: | Pennings ERA; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands. e.r.a.pennings@amsterdamumc.nl.; Cancer Center Amsterdam, Amsterdam, The Netherlands. e.r.a.pennings@amsterdamumc.nl.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands. e.r.a.pennings@amsterdamumc.nl.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. e.r.a.pennings@amsterdamumc.nl., Durmaz M; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Posthuma EFM; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Internal Medicine, Reinier de Graaf Gasthuis, Delft, The Netherlands., Issa DE; Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, The Netherlands., Chamuleau MED; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Dinmohamed AG; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.; Cancer Center Amsterdam, Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. a.dinmohamed@iknl.nl.; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. a.dinmohamed@iknl.nl. |
| Source: | Blood cancer journal [Blood Cancer J] 2024 Jan 04; Vol. 14 (1), pp. 3. Date of Electronic Publication: 2024 Jan 04. |
| Publication Type: | Letter; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38177115 AccessLevel: 2 PubType: Report PubTypeId: report PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pennings+ERA%22">Pennings ERA</searchLink>; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands. e.r.a.pennings@amsterdamumc.nl.; Cancer Center Amsterdam, Amsterdam, The Netherlands. e.r.a.pennings@amsterdamumc.nl.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands. e.r.a.pennings@amsterdamumc.nl.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. e.r.a.pennings@amsterdamumc.nl.<br /><searchLink fieldCode="AU" term="%22Durmaz+M%22">Durmaz M</searchLink>; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Visser+O%22">Visser O</searchLink>; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Posthuma+EFM%22">Posthuma EFM</searchLink>; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Internal Medicine, Reinier de Graaf Gasthuis, Delft, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Issa+DE%22">Issa DE</searchLink>; Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Chamuleau+MED%22">Chamuleau MED</searchLink>; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lugtenburg+PJ%22">Lugtenburg PJ</searchLink>; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kersten+MJ%22">Kersten MJ</searchLink>; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dinmohamed+AG%22">Dinmohamed AG</searchLink>; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.; Cancer Center Amsterdam, Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. a.dinmohamed@iknl.nl.; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. a.dinmohamed@iknl.nl. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2024 Jan 04; Vol. 14 (1), pp. 3. <i>Date of Electronic Publication: </i>2024 Jan 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38177115 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41408-023-00970-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3 Titles: – TitleFull: Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pennings ERA – PersonEntity: Name: NameFull: Durmaz M – PersonEntity: Name: NameFull: Visser O – PersonEntity: Name: NameFull: Posthuma EFM – PersonEntity: Name: NameFull: Issa DE – PersonEntity: Name: NameFull: Chamuleau MED – PersonEntity: Name: NameFull: Lugtenburg PJ – PersonEntity: Name: NameFull: Kersten MJ – PersonEntity: Name: NameFull: Dinmohamed AG IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 01 Text: 2024 Jan 04 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2044-5385 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Blood cancer journal Type: main |
| ResultId | 1 |
